Recruiting NA INTERVENTIONAL 2-arm NCT05010356

Insulin Sensitivity After Breast Cancer

Study of Molecular Causes of Metabolic Disorders in Obese Premenopausal Women After Breast Cancer

Sponsor: University of Copenhagen

Conditions Breast Cancer Insulin Sensitivity/Resistance Metabolic Disturbance Survivorship

Interventions Insulin

Updated 3 times since 2021 Last updated: Aug 10, 2021 Started: Aug 31, 2021 Primary completion: Dec 31, 2022 Completion: Sep 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05010356, this NA trial focuses on Breast Cancer and Insulin Sensitivity/Resistance and remains actively recruiting participants. Sponsored by University of Copenhagen, it has been updated 3 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Sep 2021 — Jul 2024 [monthly]

Recruiting NA

First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Copenhagen

Data source: University of Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark